ID   BMR1A_HUMAN             Reviewed;         532 AA.
AC   P36894; A8K6U9; Q8NEN8;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 2.
DT   02-NOV-2010, entry version 134.
DE   RecName: Full=Bone morphogenetic protein receptor type-1A;
DE            Short=BMP type-1A receptor;
DE            Short=BMPR-1A;
DE            EC=2.7.11.30;
DE   AltName: Full=Activin receptor-like kinase 3;
DE            Short=ALK-3;
DE   AltName: Full=Serine/threonine-protein kinase receptor R5;
DE            Short=SKR5;
DE   AltName: CD_antigen=CD292;
DE   Flags: Precursor;
GN   Name=BMPR1A; Synonyms=ACVRLK3, ALK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-2.
RC   TISSUE=Placenta;
RX   MEDLINE=93390967; PubMed=8397373;
RA   ten Dijke P., Ichijo H., Franzen P., Schulz P., Saras J.,
RA   Toyoshima H., Heldin C.-H., Miyazono K.;
RT   "Activin receptor-like kinases: a novel subclass of cell-surface
RT   receptors with predicted serine/threonine kinase activity.";
RL   Oncogene 8:2879-2887(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-2.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215; SER-216; SER-218
RP   AND SER-220, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 55-143 IN COMPLEX WITH BMP-2.
RX   PubMed=10881198; DOI=10.1038/75903;
RA   Kirsch T., Sebald W., Dreyer M.K.;
RT   "Crystal structure of the BMP-2-BRIA ectodomain complex.";
RL   Nat. Struct. Biol. 7:492-496(2000).
RN   [6]
RP   DISEASE.
RX   MEDLINE=21275975; PubMed=11381269; DOI=10.1038/88919;
RA   Howe J.R., Bair J.L., Sayed M.G., Anderson M.E., Mitros F.A.,
RA   Petersen G.M., Velculescu V.E., Traverso G., Vogelstein B.;
RT   "Germline mutations of the gene encoding bone morphogenetic protein
RT   receptor 1A in juvenile polyposis.";
RL   Nat. Genet. 28:184-187(2001).
RN   [7]
RP   VARIANTS JPS ARG-124 AND TYR-376, AND VARIANT CD ASP-338.
RX   MEDLINE=21426344; PubMed=11536076; DOI=10.1086/323703;
RA   Zhou X.-P., Woodford-Richens K., Lehtonen R., Kurose K., Aldred M.,
RA   Hampel H., Launonen V., Virta S., Pilarski R., Salovaara R.,
RA   Bodmer W.F., Conrad B.A., Dunlop M., Hodgson S.V., Iwama T.,
RA   Jaervinen H., Kellokumpu I., Kim J.C., Leggett B., Markie D.,
RA   Mecklin J.-P., Neale K., Phillips R., Piris J., Rozen P.,
RA   Houlston R.S., Aaltonen L.A., Tomlinson I.P.M., Eng C.;
RT   "Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile
RT   polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba
RT   syndromes.";
RL   Am. J. Hum. Genet. 69:704-711(2001).
RN   [8]
RP   VARIANTS JPS ASP-62; TYR-82 AND CYS-443.
RX   PubMed=12417513; DOI=10.1007/BF02557528;
RA   Sayed M.G., Ahmed A.F., Ringold J.R., Anderson M.E., Bair J.L.,
RA   Mitros F.A., Lynch H.T., Tinley S.T., Petersen G.M., Giardiello F.M.,
RA   Vogelstein B., Howe J.R.;
RT   "Germline SMAD4 or BMPR1A mutations and phenotype of juvenile
RT   polyposis.";
RL   Ann. Surg. Oncol. 9:901-906(2002).
RN   [9]
RP   VARIANT JPS ARG-130.
RX   PubMed=12136244; DOI=10.1007/s00439-002-0748-9;
RA   Friedl W., Uhlhaas S., Schulmann K., Stolte M., Loff S., Back W.,
RA   Mangold E., Stern M., Knaebel H.P., Sutter C., Weber R.G.,
RA   Pistorius S., Burger B., Propping P.;
RT   "Juvenile polyposis: massive gastric polyposis is more common in MADH4
RT   mutation carriers than in BMPR1A mutation carriers.";
RL   Hum. Genet. 111:108-111(2002).
RN   [10]
RP   VARIANT JPS THR-470.
RX   PubMed=12630959; DOI=10.1034/j.1399-0004.2003.00008.x;
RA   Kim I.J., Park J.H., Kang H.C., Kim K.H., Kim J.H., Ku J.L.,
RA   Kang S.B., Park S.Y., Lee J.S., Park J.G.;
RT   "Identification of a novel BMPR1A germline mutation in a Korean
RT   juvenile polyposis patient without SMAD4 mutation.";
RL   Clin. Genet. 63:126-130(2003).
RN   [11]
RP   INVOLVEMENT IN JUVENILE POLYPOSIS OF INFANCY.
RX   PubMed=16685657; DOI=10.1086/504301;
RA   Delnatte C., Sanlaville D., Mougenot J.-F., Vermeesch J.-R.,
RA   Houdayer C., Blois M.-C., Genevieve D., Goulet O., Fryns J.-P.,
RA   Jaubert F., Vekemans M., Lyonnet S., Romana S., Eng C.,
RA   Stoppa-Lyonnet D.;
RT   "Contiguous gene deletion within chromosome arm 10q is associated with
RT   juvenile polyposis of infancy, reflecting cooperation between the
RT   BMPR1A and PTEN tumor-suppressor genes.";
RL   Am. J. Hum. Genet. 78:1066-1074(2006).
RN   [12]
RP   INVOLVEMENT IN HEREDITARY MIXED POLYPOSIS SYNDROME 2.
RX   PubMed=16525031; DOI=10.1136/jmg.2005.034827;
RA   Cao X., Eu K.W., Kumarasinghe M.P., Li H.H., Loi C., Cheah P.Y.;
RT   "Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome
RT   10q23 by genomewide high-density single nucleotide polymorphism (SNP)
RT   scan and identification of BMPR1A loss of function.";
RL   J. Med. Genet. 43:E13-E13(2006).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-2; TYR-58; CYS-443; MET-450 AND
RP   GLN-486.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting
CC       of two type II and two type I transmembrane serine/threonine
CC       kinases. Type II receptors phosphorylate and activate type I
CC       receptors which autophosphorylate, then bind and activate SMAD
CC       transcriptional regulators. Receptor for BMP-2 and BMP-4.
CC   -!- CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-
CC       protein] phosphate.
CC   -!- COFACTOR: Magnesium or manganese (By similarity).
CC   -!- INTERACTION:
CC       P36895:Bmpr1a (xeno); NbExp=1; IntAct=EBI-1029237, EBI-2551936;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle.
CC   -!- DISEASE: Defects in BMPR1A are a cause of juvenile polyposis
CC       syndrome (JPS) [MIM:174900]; also known as juvenile intestinal
CC       polyposis (JIP). JPS is an autosomal dominant gastrointestinal
CC       hamartomatous polyposis syndrome in which patients are at risk for
CC       developing gastrointestinal cancers. The lesions are typified by a
CC       smooth histological appearance, predominant stroma, cystic spaces
CC       and lack of a smooth muscle core. Multiple juvenile polyps usually
CC       occur in a number of Mendelian disorders. Sometimes, these polyps
CC       occur without associated features as in JPS; here, polyps tend to
CC       occur in the large bowel and are associated with an increased risk
CC       of colon and other gastrointestinal cancers.
CC   -!- DISEASE: Defects in BMPR1A are a cause of Cowden disease (CD)
CC       [MIM:158350]. CD is an autosomal dominant cancer syndrome
CC       characterized by multiple hamartomas and by a high risk for
CC       breast, thyroid and endometrial cancers.
CC   -!- DISEASE: Defects in BMPR1A are the cause of hereditary mixed
CC       polyposis syndrome 2 (HMPS2) [MIM:610069]. Hereditary mixed
CC       polyposis syndrome (HMPS) is characterized by atypical juvenile
CC       polyps, colonic adenomas, and colorectal carcinomas.
CC   -!- DISEASE: A microdeletion of chromosome 10q23 involving BMPR1A and
CC       PTEN is a cause of chromosome 10q23 deletion syndrome
CC       [MIM:612242]. This syndrome shows overlapping features of the
CC       following three disorders: Bannayan-Zonana syndrome, Cowden
CC       disease and juvenile polyposis syndrome. The 10q23 microdeletion
CC       is also found in patients manifesting juvenile polyposis of
CC       infancy without cognitive disability. Juvenile polyposis of
CC       infancy is characterized by the appearance of extensive
CC       gastrointestinal juvenile hamartomatous polyposis in the first
CC       months of life.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily.
CC   -!- SIMILARITY: Contains 1 GS domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/BMPR1A";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z22535; CAA80257.1; -; mRNA.
DR   EMBL; AK291764; BAF84453.1; -; mRNA.
DR   EMBL; BC028383; AAH28383.1; -; mRNA.
DR   IPI; IPI00005731; -.
DR   PIR; I37163; I37163.
DR   RefSeq; NP_004320.2; -.
DR   UniGene; Hs.524477; -.
DR   PDB; 1ES7; X-ray; 2.90 A; B/D=55-143.
DR   PDB; 1REW; X-ray; 1.86 A; C/D=24-152.
DR   PDB; 2GOO; X-ray; 2.20 A; B/E=24-152.
DR   PDB; 2H62; X-ray; 1.85 A; C=24-152.
DR   PDB; 2H64; X-ray; 1.92 A; B=24-152.
DR   PDB; 2K3G; NMR; -; A=52-152.
DR   PDB; 2QJ9; X-ray; 2.44 A; C/D=24-152.
DR   PDB; 2QJA; X-ray; 2.60 A; C/D=24-152.
DR   PDB; 2QJB; X-ray; 2.50 A; C/D=24-152.
DR   PDBsum; 1ES7; -.
DR   PDBsum; 1REW; -.
DR   PDBsum; 2GOO; -.
DR   PDBsum; 2H62; -.
DR   PDBsum; 2H64; -.
DR   PDBsum; 2K3G; -.
DR   PDBsum; 2QJ9; -.
DR   PDBsum; 2QJA; -.
DR   PDBsum; 2QJB; -.
DR   ProteinModelPortal; P36894; -.
DR   SMR; P36894; 200-528.
DR   DIP; DIP-5793N; -.
DR   IntAct; P36894; 7.
DR   MINT; MINT-124304; -.
DR   STRING; P36894; -.
DR   PRIDE; P36894; -.
DR   Ensembl; ENST00000224764; ENSP00000224764; ENSG00000107779.
DR   Ensembl; ENST00000372037; ENSP00000361107; ENSG00000107779.
DR   GeneID; 657; -.
DR   KEGG; hsa:657; -.
DR   UCSC; uc001kdy.1; human.
DR   CTD; 657; -.
DR   GeneCards; GC10P088506; -.
DR   H-InvDB; HIX0026073; -.
DR   HGNC; HGNC:1076; BMPR1A.
DR   HPA; CAB019398; -.
DR   MIM; 158350; phenotype.
DR   MIM; 174900; phenotype.
DR   MIM; 601299; gene.
DR   MIM; 610069; phenotype.
DR   MIM; 612242; phenotype.
DR   Orphanet; 157794; Hereditary mixed polyposis syndrome.
DR   Orphanet; 2929; Juvenile gastrointestinal polyposis.
DR   Orphanet; 79076; Juvenile polyposis of infancy.
DR   PharmGKB; PA25386; -.
DR   eggNOG; prNOG13396; -.
DR   HOGENOM; HBG314718; -.
DR   HOVERGEN; HBG054502; -.
DR   InParanoid; P36894; -.
DR   OMA; DECLRAM; -.
DR   OrthoDB; EOG9JHG1D; -.
DR   PhylomeDB; P36894; -.
DR   BRENDA; 2.7.10.2; 247.
DR   BRENDA; 2.7.11.30; 247.
DR   Pathway_Interaction_DB; bmppathway; BMP receptor signaling.
DR   Reactome; REACT_12034; Signaling by BMP.
DR   NextBio; 2672; -.
DR   ArrayExpress; P36894; -.
DR   Bgee; P36894; -.
DR   CleanEx; HS_BMPR1A; -.
DR   Genevestigator; P36894; -.
DR   GO; GO:0016021; C:integral to membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0046332; F:SMAD binding; IDA:HGNC.
DR   GO; GO:0005024; F:transforming growth factor beta receptor ac...; IEA:InterPro.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0006955; P:immune response; IMP:BHF-UCL.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL.
DR   GO; GO:0045669; P:positive regulation of osteoblast different...; IMP:BHF-UCL.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted S...; IDA:BHF-UCL.
DR   GO; GO:0060391; P:positive regulation of SMAD protein nuclear...; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:HGNC.
DR   GO; GO:0007179; P:transforming growth factor beta receptor si...; TAS:ProtInc.
DR   InterPro; IPR000472; Activin_rcpt.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR003605; TGF_beta_rcpt_GS.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF08515; TGF_beta_GS; 1.
DR   SMART; SM00467; GS; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51256; GS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Kinase; Magnesium; Manganese; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Serine/threonine-protein kinase; Signal; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       Potential.
FT   CHAIN        24    532       Bone morphogenetic protein receptor type-
FT                                1A.
FT                                /FTId=PRO_0000024410.
FT   TOPO_DOM     24    152       Extracellular (Potential).
FT   TRANSMEM    153    176       Helical; (Potential).
FT   TOPO_DOM    177    532       Cytoplasmic (Potential).
FT   DOMAIN      204    233       GS.
FT   DOMAIN      234    525       Protein kinase.
FT   NP_BIND     240    248       ATP (By similarity).
FT   ACT_SITE    362    362       Proton acceptor (By similarity).
FT   BINDING     261    261       ATP (By similarity).
FT   MOD_RES     215    215       Phosphoserine.
FT   MOD_RES     216    216       Phosphoserine.
FT   MOD_RES     218    218       Phosphoserine.
FT   MOD_RES     220    220       Phosphoserine.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) (Potential).
FT   DISULFID     61     82
FT   DISULFID     63     67
FT   DISULFID     76    100
FT   DISULFID    110    124
FT   DISULFID    125    130
FT   VARIANT       2      2       P -> T (in dbSNP:rs11528010).
FT                                /FTId=VAR_041397.
FT   VARIANT      58     58       F -> Y (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041398.
FT   VARIANT      62     62       Y -> D (in JPS).
FT                                /FTId=VAR_022828.
FT   VARIANT      82     82       C -> Y (in JPS).
FT                                /FTId=VAR_022829.
FT   VARIANT     124    124       C -> R (in JPS).
FT                                /FTId=VAR_015533.
FT   VARIANT     130    130       C -> R (in JPS).
FT                                /FTId=VAR_022830.
FT   VARIANT     338    338       A -> D (in CD).
FT                                /FTId=VAR_015534.
FT   VARIANT     376    376       C -> Y (in JPS).
FT                                /FTId=VAR_015535.
FT   VARIANT     443    443       R -> C (in JPS; dbSNP:rs35619497).
FT                                /FTId=VAR_022831.
FT   VARIANT     450    450       V -> M (in dbSNP:rs55932635).
FT                                /FTId=VAR_041399.
FT   VARIANT     470    470       M -> T (in JPS).
FT                                /FTId=VAR_022832.
FT   VARIANT     486    486       R -> Q (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041400.
FT   STRAND       59     62
FT   STRAND       64     66
FT   STRAND       75     88
FT   STRAND       94    101
FT   HELIX       106    111
FT   STRAND      120    125
FT   HELIX       130    133
SQ   SEQUENCE   532 AA;  60198 MW;  00CE2DDDA3A44170 CRC64;
     MPQLYIYIRL LGAYLFIISR VQGQNLDSML HGTGMKSDSD QKKSENGVTL APEDTLPFLK
     CYCSGHCPDD AINNTCITNG HCFAIIEEDD QGETTLASGC MKYEGSDFQC KDSPKAQLRR
     TIECCRTNLC NQYLQPTLPP VVIGPFFDGS IRWLVLLISM AVCIIAMIIF SSCFCYKHYC
     KSISSRRRYN RDLEQDEAFI PVGESLKDLI DQSQSSGSGS GLPLLVQRTI AKQIQMVRQV
     GKGRYGEVWM GKWRGEKVAV KVFFTTEEAS WFRETEIYQT VLMRHENILG FIAADIKGTG
     SWTQLYLITD YHENGSLYDF LKCATLDTRA LLKLAYSAAC GLCHLHTEIY GTQGKPAIAH
     RDLKSKNILI KKNGSCCIAD LGLAVKFNSD TNEVDVPLNT RVGTKRYMAP EVLDESLNKN
     HFQPYIMADI YSFGLIIWEM ARRCITGGIV EEYQLPYYNM VPSDPSYEDM REVVCVKRLR
     PIVSNRWNSD ECLRAVLKLM SECWAHNPAS RLTALRIKKT LAKMVESQDV KI
//
